SG

Sanjeev Gupta

Active Director Director DIN 03602898
DIN 03602898 First appointment Aug 2011 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2011
Shareholding value •••• Premium profile

About Sanjeev Gupta

Data last updated:

Sanjeev Gupta is a Director at Dicore Pharmaceuticals Private Limited (since 2011). The company operates in Trading. Dicore Pharmaceuticals Private Limited reported revenue of ₹8.3 Lakh (FY 2024).

DIN 03602898
Primary Designation Director
Industry Trading
First Appointment 30 Aug 2011
Oldest Company Age 15 yrs
Largest company Dicore Pharmaceuticals Private Limited · ₹8.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Aug 20112011₹8.3 Lakh (FY 2024)Active

Board colleagues of Sanjeev Gupta

NameDINCompanyDesignation
Rupa Gupta03602896Dicore Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dicore Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanjeev Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjeev Gupta

Sanjeev Gupta currently holds 1 directorship: Dicore Pharmaceuticals Private Limited (Director, since 30 Aug 2011, revenue ₹8.3 Lakh (FY 2024)).

Sanjeev Gupta was first appointed on 30 Aug 2011 as Director at Dicore Pharmaceuticals Private Limited.

The current boards of Sanjeev Gupta's companies include Rupa Gupta (Dicore Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available